Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.（DAWN）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · DAWN · 截至 2025年9月30日
股东结构概览
176
机构持有人数
▼ 4 vs Q2
$603.97M
机构持仓总市值
▲ $42.79M vs Q2
103.33M
总流通股
freeFloat 69.05%
85.68M
13F 申报持股数
▼ 658,208 vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
DAWN 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
FMR LLC pharmaceutical preparations | 10.10M | 9.80% | 9.80% | $71.19B | Nov 13, 2025 | ▼ 1.25M |
BLACKROCK, INC. pharmaceutical preparations | 9.00M | 8.73% | 8.73% | $63.46B | Nov 12, 2025 | ▼ 829.0K |
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC pharmaceutical preparations | 6.43M | 6.24% | 6.24% | $45.33B | Nov 13, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 6.18M | 6.00% | 6.00% | $43.58B | Nov 7, 2025 | ▲ 4.8K |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) pharmaceutical preparations | 4.71M | 4.57% | 4.57% | $33.17B | Nov 14, 2025 | ▲ 982.3K |
FRANKLIN RESOURCES INC pharmaceutical preparations | 3.48M | 3.37% | 3.37% | $24.51B | Nov 13, 2025 | ▼ 620.6K |
RUBRIC CAPITAL MANAGEMENT LP pharmaceutical preparations | 3.38M | 3.28% | 3.28% | $23.81B | Nov 14, 2025 | NEW |
STATE STREET CORP pharmaceutical preparations | 3.24M | 3.14% | 3.14% | $22.85B | Nov 14, 2025 | ▲ 550.8K |
VESTAL POINT CAPITAL, LP pharmaceutical preparations | 2.67M | 2.60% | 2.60% | $18.86B | Nov 14, 2025 | ▼ 325.0K |
PICTET ASSET MANAGEMENT HOLDING SA pharmaceutical preparations | 2.37M | 2.30% | 2.30% | $16.73B | Nov 18, 2025 | ▼ 1.35M |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
24
增持
+5.87M 股4
新建仓
首次建仓16
减持
−6.58M 股0
清仓
完全退出净股数变化（前50家）
714.3K
+5.87M / −6.58M
净新增持仓人
+12
新建 4 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
DAWN 内幕交易记录
数据来源：SEC Form 4
0
买入笔数
44
卖出笔数
0.00
买卖比
$4M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
AI Day1 LLC 10 percent owner | Apr 23, 2026 | U-Tender | 12,929,322 | $21.50 | $277.98M | 0 | Form 4 ↗ |
AI Day1 LLC 10 percent owner | Apr 23, 2026 | D-Return | 827,586 | $0.00 | $82.759 | 0 | Form 4 ↗ |
Bender Jeremy CHIEF EXECUTIVE OFFICER | Apr 23, 2026 | D-Return | 808,285 | $0.00 | $80.829 | 0 | Form 4 ↗ |
Bender Jeremy CHIEF EXECUTIVE OFFICER | Apr 23, 2026 | D-Return | 286,000 | $8.99 | $2.57M | 0 | Form 4 ↗ |
Bender Jeremy CHIEF EXECUTIVE OFFICER | Apr 23, 2026 | D-Return | 355,000 | $11.16 | $3.96M | 0 | Form 4 ↗ |
Bender Jeremy CHIEF EXECUTIVE OFFICER | Apr 23, 2026 | D-Return | 222,188 | — | — | 0 | Form 4 ↗ |
VASCONCELLES MICHAEL Head of Research and Dev. | Apr 23, 2026 | D-Return | 4,397 | $0.00 | $0.44 | 0 | Form 4 ↗ |
VASCONCELLES MICHAEL Head of Research and Dev. | Apr 23, 2026 | D-Return | 346,000 | $6.64 | $2.30M | 0 | Form 4 ↗ |
VASCONCELLES MICHAEL Head of Research and Dev. | Apr 23, 2026 | D-Return | 171,000 | $11.16 | $1.91M | 0 | Form 4 ↗ |
VASCONCELLES MICHAEL Head of Research and Dev. | Apr 23, 2026 | D-Return | 106,875 | — | — | 0 | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Day One Biopharmaceuticals, Inc.（DAWN）主要由机构投资者持有，机构持股比例约为 82.9%。公司内部人员持股约 30.95%，散户及公众持股约占剩余的 0.00%。
Day One Biopharmaceuticals, Inc. 最大机构股东为 FMR LLC，截至 September 30, 2025 持有约 10.10 million 股，占总流通股的 9.80%。
目前共有 176 家机构持有 DAWN 股票，合计持仓市值约 $603,966,780，数据来源为最新 SEC 13F 申报。
常见问题
DAWN ownershipDay One Biopharmaceuticals, Inc.（DAWN）主要由机构投资者持有，机构持股约 82.9%。最大股东为 FMR LLC，持股比例 9.80%。内部人员持股约 30.95%。数据来源 SEC Form 13F，截至 September 30, 2025。